1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-210

PAR-25-210National Institutes of HealthR33

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Oct 31, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate the development of effective precision probiotic interventions…

Related NIH announcements1

Companion announcements with the same title first, then other open R33 announcements on related subjects with at least two weeks to go.

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

PAR-25-211National Institutes of Health3 review criteria on file

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Immunology), with at least two weeks to apply.

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

PAS-27-028National Institutes of Health3 review criteria on fileagency framework

—

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

PAR-27-015National Institutes of Health3 review criteria on file

$300k

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

PAR-27-082National Institutes of Health13 review criteria on file

—

Everything open tagged Immunology

Hiring in this research area now

All immunology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-210.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.